MD-2

Immunobiology

Volumn 211, Issue 6-8, 2006, Pages 437-447

  Visintin, Alberto ^a   Iliev, Dimitar B ^b,c   Monks, Brian G ^a   Halmen, Kristen A ^a   Golenbock, Douglas T ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^c UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

Bacteria recognition; Inflammation; Innate immunity; LPS; MD 2; TLR4

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIUM LIPOPOLYSACCHARIDE; CYSTEINE DERIVATIVE; IMMUNOGLOBULIN; PROTEIN MD 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 4 AGONIST; UNCLASSIFIED DRUG;

CARBOHYDRATE ANALYSIS; CELL IMMORTALIZATION; DRUG MECHANISM; GENE MUTATION; GENETIC CODE; GRAM NEGATIVE INFECTION; HUMAN; MACROPHAGE ACTIVATION; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS;

EID: 33747360450     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2006.05.010     Document Type: Review

References (78)

1. Abreu M.T., Vora P., Faure E., Thomas L.S., Arnold E.T., and Arditi M. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J. Immunol. 167 (2001) 1609-1616
2. Abreu M.T., Arnold E.T., Thomas L.S., Gonsky R., Zhou Y., Hu B., and Arditi M. TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J. Biol. Chem, 277 (2002) 20431-20437
3. Abreu M.T., Thomas L.S., Arnold E.T., Lukasek K., Michelsen K.S., and Arditi M. TLR signaling at the intestinal epithelial interface. J. Endotoxin Res. 9 (2003) 322-330
4. Aderem A. Phagocytosis and the inflammatory response. J. Infect. Dis. 187 Suppl 2 (2003) S340-S345
5. Akashi S., Saitoh S., Wakabayashi Y., Kikuchi T., Takamura N., Nagai Y., Kusumoto Y., Fukase K., Kusumoto S., Adachi Y., Kosugi A., and Miyake K. Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14. J. Exp. Med. 198 (2003) 1035-1042
6. Bell J.K., Botos I., Hall P.R., Askins J., Shiloach J., Segal D.M., and Davies D.R. The molecular structure of the Toll-like receptor 3 ligand-binding domain. Proc. Natl. Acad. Sci. USA 102 (2005) 10976-10980
7. Bentala H., Verweij W.R., Huizinga-Van der Vlag A., van Loenen-Weemaes A.M., Meijer D.K., and Poelstra K. Removal of phosphate from lipid A as a strategy to detoxify lipopolysaccharide. Shock 18 (2002) 561-566
8. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430 (2004) 257-263
9. Beutler B., and Rehli M. Evolution of the TIR, tolls and TLRs: functional inferences from computational biology. Curr. Top. Microbiol. Immunol. 270 (2002) 1-21
10. Blais D.R., Vascotto S.G., Griffith M., and Altosaar I. LBP and CD14 secreted in tears by the lacrimal glands modulate the LPS response of corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 46 (2005) 4235-4244
11. Choe J., Kelker M.S., and Wilson I.A. Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science 309 (2005) 581-585
12. Chow J.C., Young D.W., Golenbock D.T., Christ W.J., and Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274 (1999) 10689-10692
13. da Silva Correia J., and Ulevitch R.J. MD-2 and TLR4 N-linked glycosylations are important for a functional lipopolysaccharide receptor. J. Biol. Chem. 277 (2002) 1845-1854
14. Divanovic S., Trompette A., Atabani S.F., Madan R., Golenbock D.T., Visintin A., Finberg R.W., Tarakhovsky A., Vogel S.N., Belkaid Y., Kurt-Jones E.A., and Karp C.L. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat. Immunol. 6 (2005) 571-578
15. Du X., Poltorak A., Silva M., and Beutler B. Analysis of Tlr4-mediated LPS signal transduction in macrophages by mutational modification of the receptor. Blood Cells Mol. Dis. 25 (1999) 328-338
16. Fahy E., Subramaniam S., Brown H.A., Glass C.K., Merrill Jr. A.H., Murphy R.C., Raetz C.R., Russell D.W., Seyama Y., Shaw W., Shimizu T., Spener F., van Meer G., VanNieuwenhze M.S., White S.H., Witztum J.L., and Dennis E.A. A comprehensive classification system for lipids. J. Lipid Res. 46 (2005) 839-861
17. Feulner J.A., Lu M., Shelton J.M., Zhang M., Richardson J.A., and Munford R.S. Identification of acyloxyacyl hydrolase, a lipopolysaccharide-detoxifying enzyme, in the murine urinary tract. Infect. Immunol. 72 (2004) 3171-3178
18. Fujimoto T., Yamazaki S., Eto-Kimura A., Takeshige K., and Muta T. The amino-terminal region of toll-like receptor 4 is essential for binding to MD-2 and receptor translocation to the cell surface. J. Biol. Chem. 279 (2004) 47431-47437
19. Gangloff M., and Gay N.J. MD-2: the Toll 'gatekeeper' in endotoxin signalling. Trends Biochem. Sci. 29 (2004) 294-300
20. Gioannini T.L., Teghanemt A., Zhang D., Coussens N.P., Dockstader W., Ramaswamy S., and Weiss J.P. Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations. Proc. Natl. Acad. Sci. USA 101 (2004) 4186-4191
21. Gruber A., Mancek M., Wagner H., Kirschning C.J., and Jerala R. Structural model of MD-2 and functional role of its basic amino acid clusters involved in cellular lipopolysaccharide recognition. J. Biol. Chem. 279 (2004) 28475-28482
22. Hamann L., Kumpf O., Muller M., Visintin A., Eckert J., Schlag P.M., and Schumann R.R. A coding mutation within the first exon of the human MD-2 gene results in decreased lipopolysaccharide-induced signaling. Genes Immun. 5 (2004) 283-288
23. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., and Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162 (1999) 3749-3752
24. Hyakushima N., Mitsuzawa H., Nishitani C., Sano H., Kuronuma K., Konishi M., Himi T., Miyake K., and Kuroki Y. Interaction of soluble form of recombinant extracellular TLR4 domain with MD-2 enables lipopolysaccharide binding and attenuates TLR4-mediated signaling. J. Immunol. 173 (2004) 6949-6954
25. Ichikawa S., Takai T., Inoue T., Yuuki T., Okumura Y., Ogura K., Inagaki F., and Hatanaka H. NMR study on the major mite allergen Der f2: its refined tertiary structure, epitopes for monoclonal antibodies and characteristics shared by ML protein group members. J. Biochem. (Tokyo) 137 (2005) 255-263
26. Iliev D.B., Roach J.C., Mackenzie S., Planas J.V., and Goetz F.W. Endotoxin recognition: in fish or not in fish?. FEBS Lett. 579 (2005) 6519-6528
27. Inohara N., and Nunez G. ML - a conserved domain involved in innate immunity and lipid metabolism. Trends Biochem. Sci. 27 (2002) 219-221
28. Iwami K.I., Matsuguchi T., Masuda A., Kikuchi T., Musikacharoen T., and Yoshikai Y. Cutting edge: naturally occurring soluble form of mouse Toll-like receptor 4 inhibits lipopolysaccharide signaling. J. Immunol. 165 (2000) 6682-6686
29. Jia H.P., Kline J.N., Penisten A., Apicella M.A., Gioannini T.L., Weiss J., and McCray Jr. P.B. Endotoxin responsiveness of human airway epithelia is limited by low expression of MD-2. Am. J. Physiol. Lung Cell Mol. Physiol. 287 (2004) L428-L437
30. Jiang Z., Georgel P., Du X., Shamel L., Sovath S., Mudd S., Huber M., Kalis C., Keck S., Galanos C., Freudenberg M., and Beutler B. CD14 is required for MyD88-independent LPS signaling. Nat. Immunol. 6 (2005) 565-570
31. Kato K., Morrison A.M., Nakano T., Tashiro K., and Honjo T. ESOP-1, a secreted protein expressed in the hematopoietic, nervous, and reproductive systems of embryonic and adult mice. Blood 96 (2000) 362-364
32. Kawasaki K., Nogawa H., and Nishijima M. Identification of mouse MD-2 residues important for forming the cell surface TLR4-MD-2 complex recognized by anti-TLR4-MD-2 antibodies, and for conferring LPS and taxol responsiveness on mouse TLR4 by alanine-scanning mutagenesis. J. Immunol. 170 (2003) 413-420
33. Keber M.M., Gradisar H., and Jerala R. MD-2 and Der p2 - a tale of two cousins or distant relatives?. J. Endotoxin Res. 11 (2005) 186-192
34. Kennedy M.N., Mullen G.E., Leifer C.A., Lee C., Mazzoni A., Dileepan K.N., and Segal D.M. A complex of soluble MD-2 and lipopolysaccharide serves as an activating ligand for Toll-like receptor 4. J. Biol. Chem. 279 (2004) 34698-34704
35. Kumagai N., Fukuda K., Fujitsu Y., Lu Y., Chikamoto N., and Nishida T. Lipopolysaccharide-induced expression of intercellular adhesion molecule-1 and chemokines in cultured human corneal fibroblasts. Invest. Ophthalmol. Vis. Sci. 46 (2005) 114-120
36. Latz E., Visintin A., Lien E., Fitzgerald K.A., Monks B.G., Kurt-Jones E.A., Golenbock D.T., and Espevik T. Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J. Biol. Chem. 277 (2002) 47834-47843
37. LeBouder E., Rey-Nores J.E., Rushmere N.K., Grigorov M., Lawn S.D., Affolter M., Griffin G.E., Ferrara P., Schiffrin E.J., Morgan B.P., and Labeta M.O. Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J. Immunol. 171 (2003) 6680-6689
38. Lien E., Means T.K., Heine H., Yoshimura A., Kusumoto S., Fukase K., Fenton M.J., Oikawa M., Qureshi N., Monks B., Finberg R.W., Ingalls R.R., and Golenbock D.T. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 105 (2000) 497-504
39. Lu M., Zhang M., Takashima A., Weiss J., Apicella M.A., Li X.H., Yuan D., and Munford R.S. Lipopolysaccharide deacylation by an endogenous lipase controls innate antibody responses to Gram-negative bacteria. Nat. Immunol. 6 (2005) 989-994
40. Mancek M., Pristovsek P., and Jerala R. Identification of LPS-binding peptide fragment of MD-2, a Toll-receptor accessory protein. Biochem. Biophys. Res. Commun. 292 (2002) 880-885
41. Matzinger P. The danger model: a renewed sense of self. Science 296 (2002) 301-305
42. Medzhitov R., Preston-Hurlburt P., and Janeway Jr. C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 (1997) 394-397
43. Miyake K. Innate recognition of lipopolysaccharide by CD14 and toll-like receptor 4-MD-2: unique roles for MD-2. Int. Immunopharmacol. 3 (2003) 119-128
44. Monick M.M., Yarovinsky T.O., Powers L.S., Butler N.S., Carter A.B., Gudmundsson G., and Hunninghake G.W. Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin. J. Biol. Chem. 278 (2003) 53035-53044
45. Moran J.V., DeBerardinis R.J., and Kazazian Jr. H.H. Exon shuffling by L1 retrotransposition. Science 283 (1999) 1530-1534
46. Mullen G.E., Kennedy M.N., Visintin A., Mazzoni A., Leifer C.A., Davies D.R., and Segal D.M. The role of disulfide bonds in the assembly and function of MD-2. Proc. Natl. Acad. Sci. USA 100 (2003) 3919-3924
47. Muzio M., Natoli G., Saccani S., Levrero M., and Mantovani A. The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J. Exp. Med. 187 (1998) 2097-2101
48. Nagai Y., Akashi S., Nagafuku M., Ogata M., Iwakura Y., Akira S., Kitamura T., Kosugi A., Kimoto M., and Miyake K. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 3 (2002) 667-672
49. Nagai Y., Shimazu R., Ogata H., Akashi S., Sudo K., Yamasaki H., Hayashi S., Iwakura Y., Kimoto M., and Miyake K. Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. Blood 99 (2002) 1699-1705
50. Nattermann J., Du X., Wei Y., Shevchenko D., and Beutler B. Endotoxin-mimetic effect of antibodies against Toll-like receptor 4. J. Endotoxin Res. 6 (2000) 257-264
51. Nishitani C., Mitsuzawa H., Hyakushima N., Sano H., Matsushima N., and Kuroki Y. The Toll-like receptor 4 region Glu24-Pro34 is critical for interaction with MD-2. Biochem. Biophys. Res. Commun. 328 (2005) 586-590
52. Ohnishi T., Muroi M., and Tanamoto K. N-linked glycosylations at Asn(26) and Asn(114) of human MD-2 are required for toll-like receptor 4-mediated activation of NF-kappaB by lipopolysaccharide. J. Immunol. 167 (2001) 3354-3359
53. Poltorak A., He X., Smirnova I., Liu M.Y., Huffel C.V., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., and Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 (1998) 2085-2088
54. Poltorak A., Ricciardi-Castagnoli P., Citterio S., and Beutler B. Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation. Proc. Natl. Acad. Sci. USA 97 (2000) 2163-2167
55. Pugin J., Stern-Voeffray S., Daubeuf B., Matthay M.A., Elson G., and Dunn-Siegrist I. Soluble MD-2 activity in plasma from patients with severe sepsis and septic shock. Blood 104 (2004) 4071-4079
56. Raetz C.R., and Whitfield C. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71 (2002) 635-700
57. Randow F., and Seed B. Endoplasmic reticulum chaperone gp96 is required for innate immunity but not cell viability. Nat. Cell Biol. 3 (2001) 891-896
58. Re F., and Strominger J.L. Monomeric recombinant MD-2 binds toll-like receptor 4 tightly and confers lipopolysaccharide responsiveness. J. Biol. Chem. 277 (2002) 23427-23432
59. Rock F.L., Hardiman G., Timans J.C., Kastelein R.A., and Bazan J.F. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA 95 (1998) 588-593
60. Saitoh S., Akashi S., Yamada T., Tanimura N., Kobayashi M., Konno K., Matsumoto F., Fukase K., Kusumoto S., Nagai Y., Kusumoto Y., Kosugi A., and Miyake K. Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization. Int. Immunol. 16 (2004) 961-969
61. Schromm A.B., Lien E., Henneke P., Chow J.C., Yoshimura A., Heine H., Latz E., Monks B.G., Schwartz D.A., Miyake K., and Golenbock D.T. Molecular genetic analysis of an endotoxin nonresponder mutant cell line: a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling. J. Exp. Med. 194 (2001) 79-88
62. Schubert W.D., Urbanke C., Ziehm T., Beier V., Machner M.P., Domann E., Wehland J., Chakraborty T., and Heinz D.W. Structure of internalin, a major invasion protein of Listeria monocytogenes, in complex with its human receptor E-cadherin. Cell 111 (2002) 825-836
63. Seong S.Y., and Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 4 (2004) 469-478
64. Shimazu R., Akashi S., Ogata H., Nagai Y., Fukudome K., Miyake K., and Kimoto M. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189 (1999) 1777-1782
65. Termeer C., Benedix F., Sleeman J., Fieber C., Voith U., Ahrens T., Miyake K., Freudenberg M., Galanos C., and Simon J.C. Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 195 (2002) 99-111
66. Triantafilou M., and Triantafilou K. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol. 23 (2002) 301-304
67. Triantafilou K., Triantafilou M., and Dedrick R.L. A CD14-independent LPS receptor cluster. Nat. Immunol. 2 (2001) 338-345
68. Tsoi S., Park K.C., Kay H.H., O'Brien T.J., Podor E., Sun G., Douglas S.E., Brown L.L., and Johnson S.C. Identification of a transcript encoding a soluble form of toll-like receptor 5 (TLR5) in Atlantic salmon during Aeromonas salmonicida infection. Vet. Immunol. Immunopathol. 109 (2006) 183-187
69. Tsujita T., Tsukada H., Nakao M., Oshiumi H., Matsumoto M., and Seya T. Sensing bacterial flagellin by membrane and soluble orthologs of Toll-like receptor 5 in rainbow trout (Onchorhynchus mikiss). J. Biol. Chem. 279 (2004) 48588-48597
70. Tsuneyoshi N., Fukudome K., Kohara J., Tomimasu R., Gauchat J.F., Nakatake H., and Kimoto M. The functional and structural properties of MD-2 required for lipopolysaccharide binding are absent in MD-1. J. Immunol. 174 (2005) 340-344
71. van Duin D., Medzhitov R., and Shaw A.C. Triggering TLR signaling in vaccination. Trends Immunol. 27 (2006) 49-55
72. Viriyakosol S., Tobias P.S., Kitchens R.L., and Kirkland T.N. MD-2 binds to bacterial lipopolysaccharide. J. Biol. Chem. 276 (2001) 38044-38051
73. Viriyakosol S., Tobias P.S., and Kirkland T.N. Mutational analysis of membrane and soluble forms of human MD-2. J. Biol. Chem. 281 (2006) 11955-11964
74. Visintin A., Mazzoni A., Spitzer J.A., and Segal D.M. Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4. Proc. Natl. Acad. Sci. USA 98 (2001) 12156-12161
75. Visintin A., Latz E., Monks B.G., Espevik T., and Golenbock D.T. Lysines 128 and 132 enable lipopolysaccharide binding to MD-2, leading to Toll-like receptor-4 aggregation and signal transduction. J. Biol. Chem. 278 (2003) 48313-48320
76. Visintin A., Halmen K.A., Latz E., Monks B.G., and Golenbock D.T. Pharmacological inhibition of endotoxin responses is achieved by targeting the TLR4 coreceptor, MD-2. J. Immunol. 175 (2005) 6465-6472
77. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., and Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249 (1990) 1431-1433
78. Zhang H., Tay P.N., Cao W., Li W., and Lu J. Integrin-nucleated Toll-like receptor (TLR) dimerization reveals subcellular targeting of TLRs and distinct mechanisms of TLR4 activation and signaling. FEBS Lett. 532 (2002) 171-176